Department of Medicinal Chemistry, Merck Research Laboratories, West Point, PA 19486, USA. karen_brashear@merck.com
Abstract:
A series of novel, highly potent alpha(v)beta(3) receptor antagonists with favorable pharmacokinetic profiles has been identified. In this series of antagonists, 2-aryl beta-amino acids function as potent aspartic acid replacements.